Equinox’s new Women’s Arc program merges biomarker testing, wearable insights, and hormone-aligned training to redefine women’s health, performance, and longevity.
The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...
Big news in the menopause world: The Food and Drug Administration has just approved the drug elinzanetant as a non-hormonal ...
Clearance of Lynkuet provides a new alternative to hormone-based treatment for hot flashes and sets up a market battle with Astellas Pharma’s Veozah.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback